臨床進度

	Preclinical PRE	Phase I PH I	Phase II PH II	Phase III PH III
Oncology NSCLC (mono) NSCLC (combination) US FDA IND 105226 AML (Russia) AML (US) US FDA IND 157917 Pancreatic Cancer US FDA IND 133158
Infectious Disease Covid-19 US FDA IND 149841 HBV
Neurodegenerative Disease Alzheimer’s Disease